ARCHIVES

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

This article is from The Cancer Letter archive.

Vol. 26 No. 22 | June 2, 2000

Download PDF Visit The Full Archive

Related Articles

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005

The Cancer Letter Offers FAX Delivery

January 7, 1994

In Brief: NBCC Plans Meetings On Quality Of Care, Potential Environmental Causes Of Disease

February 20, 1998

Only 20% of Doctors Advise CRC According To Guidelines

October 29, 2010

Review Group Report: NCI Role In Drug Development Seen As Information Provider

November 6, 1998

Gene Expression Analyses Can Guide MDS Treatments

December 30, 2011